The response to treatment and survival outcomes are influenced by the histological and genetic characteristics of gliomas, particularly tumor grade, isocitrate dehydrogenase (IDH) mutation status, and 1p/19q codeletion (2, 3). Here, IDH3A is linked to neoplasm.